10:40am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Pharma
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Companies
Abbvie Inc
$262.62
▼ $3.17 (−1.19%) today
Markets open · 4:09pm ET
ABBV Coverage
Page 2710:05am ET
Health and Healthcare
2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
10:00am ET
Health and Healthcare
Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
11:25am ET
Health and Healthcare
Short Sellers Back Way Off Major Pharma
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
10:55am ET
Health and Healthcare
Why AbbVie Won Big in Q3, and Can Keep Winning
AbbVie reported better-than-expected third-quarter before the markets opened on Friday due to strong sales of Humira and Imbruvica.
Chris Lange 10:20am ET
Health and Healthcare
Short Sellers Hike Bets in Major Pharma
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
10:45am ET
Health and Healthcare
Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
8:30am ET
Health and Healthcare
4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings
These four top companies all have data that could move the shares the rest of this year and into 2018. All have been around for years and will remain sector leaders for…
10:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More
courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull…
8:25am ET
Investing
5 Stocks to Buy That Are Much Cheaper Than the S&P 500
While it seems everything is fully priced, the good news for investors is that there is still a plethora of stocks that are cheaper than the overall S&P 500.
12:45pm ET
Health and Healthcare
AbbVie and Amgen Reach Global Resolution of Humira
AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen.
9:00am ET
Health and Healthcare
Major Pharma Short Interest Piles On
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More
The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean and Under Armour.